Innoviva (INVA) Stock Price Target 2026

The average analyst price target for Innoviva is $37.57, 97.7% above the current price. Of 5 analysts, 4 rate it Buy and 1 Sell. Targets range from $17 to $55. The latest change came on Nov 5, 2026, when Oppenheimer lowered its price target on Innoviva from $35 to $34 and kept an Outperform rating.

The Average Analyst Price Target for Innoviva is $37.57.

Price Target Range — 7 Quarters

Analyst Consensus — 5 Analysts

4Buy

1Sell

Consensus RatingBuy# Analysts5Avg. Consensus PT$37.57Upside to Avg. PT+97.7%

Rating Trend — Last 9 Months

Latest Upgrades and Downgrades for Innoviva Stock

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Nov 5, 2026	Oppenheimer	Les Sulewski	PT Cut	Outperform	$35→$34
Sep 23, 2026	Oppenheimer	Les Sulewski	Assumes	Outperform	$35
Aug 7, 2026	Cantor Fitzgerald	Steve Seedhouse	PT Cut	Overweight	$36→$34
Jun 22, 2026	BTIG	Julian Harrison	Maintained	Buy	$42
Jun 1, 2026	HC Wainwright & Co.	Raghuram Selvaraju	Maintained	Buy	$46
May 26, 2026	BTIG	Julian Harrison	Maintained	Buy	$42
May 7, 2026	BTIG	Julian Harrison	PT Raise	Buy	$35→$42
Feb 26, 2026	BTIG	Julian Harrison	Maintained	Buy	$35
Feb 17, 2026	BTIG	Julian Harrison	Initiate	Buy	$35
Dec 16, 2025	HC Wainwright & Co.	Raghuram Selvaraju	PT Raise	Buy	$45→$46
Nov 6, 2025	Cantor Fitzgerald	Steve Seedhouse	PT Raise	Overweight	$29→$31
Sep 30, 2025	Goldman Sachs	Asad Haider	Initiate	Sell	$17
Aug 11, 2025	Oppenheimer	Trevor Allred	Initiate	Outperform	$35
Aug 11, 2025	HC Wainwright & Co.	Raghuram Selvaraju	PT Raise	Buy	$40→$45
Jul 14, 2025	HC Wainwright & Co.	Raghuram Selvaraju	Initiate	Buy	$40
Jul 11, 2025	Cantor Fitzgerald	Steve Seedhouse	Initiate	Overweight	$26
Mar 7, 2025	Scotiabank	Louise Chen	Initiate	Sector Outperform	$55
Aug 1, 2024	Cantor Fitzgerald	Louise Chen	Maintained	Overweight	—
Jul 30, 2024	Cantor Fitzgerald	Louise Chen	Maintained	Overweight	—
Jun 20, 2024	Cantor Fitzgerald	Louise Chen	Maintained	Overweight	—